USD 377.87 million
Global Biopharmaceuticals Market Size, Share, Growth Analysis, By By Product type(Monoclonal Antibodies, Gene Therapies), By Application(Oncology, Inflammatory Diseases), By End-use(Health And Care, Biopharma Companies) - Industry Forecast 2023-2030
Report ID:
SQMIG35H2058 |
Region:
Global |
Published Date: April, 2024
Pages:
219
|
Tables:
99 |
Figures:
67
Global Biopharmaceuticals Market Insights
Global Biopharmaceuticals Market was valued around USD 377.87 million in 2022 and is expected to rise from USD 407.34 million in 2023 to reach USD 742.87 million by the end of 2031, by recording a CAGR of 7.80% during the forecast period (2024-2031).
A biopharmaceutical is a business that provides services to other biopharmaceutical companies on a contract basis, including packaging and drug manufacturing. This permits major biopharmaceutical associations to rethink their assembling activity, hence empowering them to zero in on drug revelation and medication promoting. Due to a lack of in-house production capacity, a number of small biotechnology companies outsource fill and finish manufacturing, which helps reduce capital expenditures. Biopharmaceuticals are drugs that are used for medical purposes and are made by using biotechnology to extract proteins and nucleic acids directly from the biological source. The majority of biopharmaceuticals are pharmaceuticals derived from living things. Genetically modified plants and animals are referred to as transgenic organisms. This process is used to produce biopharmaceuticals, but it is a highly contentious approach that is still in the trial phase. One of the first substances to be approved for therapeutic purposes was recombinant human insulin; currently, nearly 300 biopharmaceutical products have been approved and are available for purchase. The growth of this market is being driven by a few key factors, including an expanding geriatric population, rising levels of awareness, and rising costs associated with healthcare. In addition, this market is anticipated to benefit from ongoing R&D and approval for newer biopharmaceutical products. However, one of the industry's biggest obstacles is the high cost of these drugs, which must be significantly reduced to make the business viable.
US Biopharmaceuticals Market is poised to grow at a sustainable CAGR for the next forecast year.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Biopharma Companies
Fastest Growth
Health and Care
Growth Rate
7.80% CAGR
Global Biopharmaceuticals Market ($ Mn)
Country Share for North America Region (%)
Global Biopharmaceuticals Market Size By End Use ($ Mn)
Global Biopharmaceuticals Market Size By End use (%)
To get more reports on the above market click here to Buy The Report
Global Biopharmaceuticals Market Segmental Analysis
The global biopharmaceuticals market is segmented on the basis of product type, application, end use, and region. With respect to segmentation by product type, the market is segmented into the Monoclonal Antibodies, Gene Therapies, Thrombolytics and Anticoagulants, and Recombinant Protein. Based on classification by application, the market is categorized into Oncology, Inflammatory Diseases, Cardiology, Neurology, Autoimmune Disorders, Metabolic Disorders, Hormonal Disorders, and Others. With respect to categorization by end use, the market is grouped into Health and Care, Biopharma Companies, Diagnostic Labs, Clinical Research Institute, Clinical Research Organizations (CROs), and Others. Region wise, the market is widespread into North America, Europe, Asia-Pacific, Latin America and the Middle East and Africa.
Biopharmaceuticals Market Analysis by Product type
Based on the product type, In 2023, the Recombinant Protein Segment commanded the largest share of the market.This growth is due to the use of microorganisms in gene therapy and the production of human proteins using recombinant DNA technology.Since 1985, linear growth has been stimulated with recombinant growth hormone.IGF-1 (insulin-like growth factor 1) secretion is the primary mechanism by which rGH functions.In recent years, rhGH has helped children with growth retardation who are GH deficient (GHD).The use of recombinant DNA technology to treat serious illnesses like these is further propelling the biopharmaceutical market's expansion. In addition, it is anticipated that the Monoclonal Antibodies segment will expand at the fastest CAGR of 8.8% between the years 2024 and 2031 due to the widespread use of monoclonal antibodies in oncology to treat a variety of cancers and the key benefits of monoclonal antibodies in the diagnosis and treatment of "cancer," "myocardial infarctions," and development therapy for "neoplastic and hematopoietic disease," as well as a plethora.
Biopharmaceuticals Market Analysis by End use
On the basis of end use, The Health and Care, Biopharma Companies, Diagnostic Labs, Clinical Research Institute, Clinical Research Organizations (CROs), and Others. In 2023, the biopharma companies segment held the largest share of the market.This growth is due to the significant advancements in new medicine and its application to the treatment of complex diseases.This market is also expanding as a result of the recent progress in molecular medicine research and development made by numerous prominent market players and government agencies. In addition, it is anticipated that the Clinical Research Organizations segment will expand at the fastest CAGR of 9.1% between the years 2024 and 2031 as a result of the expansion of research into the development of novel molecular drugs through the use of molecular biology and the assistance that clinical research organizations provide to patients in the form of individualized treatment in order to diagnose and treat complex diseases.
Global Biopharmaceuticals Market By End Use (%), 2023 (%)
To get detailed analysis on other segments, Request For Free Sample Report
Global Biopharmaceuticals Market Regional Insights
North America Expected to Dominate the Market, The biopharmaceuticals market in North America is being driven primarily by the rising incidence of chronic diseases in the United States and rising investments in R&D.In the field of life sciences, the United States has been acknowledged as the global innovation capital.In the early stages of biopharmaceutical companies, it participates in global capital investments. The North American biopharmaceuticals market is anticipated to expand as a result of the increase in COVID-19-related clinical trials.Nearly 1,750 clinical trials for the development of vaccines and drugs for the treatment of COVID-19 were in progress as of January 2021, according to the Pharmaceutical Research and Manufacturers of America. 420 of these clinical trials were based in the United States. Globocan estimates that there will be 2,281,658 new cases of cancer in the United States in 2020.Additionally, 612,390 deaths were recorded. The studied market is driven by the demand for effective therapeutics and the high incidence of cancer.
In Walk 2020, Thermo Fisher Logical Inc. contributed almost USD 475 million to grow its biologics, cell and quality treatment, and medication item improvement offices and increment its worldwide business abilities. In a similar vein, Eli Lilly and Company agreed to acquire Dermira, a biopharmaceutical company, in January 2020.The addition of Dermira's lebrikizumab, an IL-13 antibody intended for the treatment of moderate-to-severe atopic dermatitis, to the company's biopharmaceutical portfolio aided this acquisition.
As a result, the studied market is anticipated to expand significantly in North America over the forecast period due to the aforementioned factors.
Global Biopharmaceuticals Market By Geography, 2024-2031
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Global Biopharmaceuticals Market Dynamics
Biopharmaceuticals Market Drivers
Increase in Chronic Disease Patient Pool to Propel Growth
- Around the world, chronic diseases such as cancer, diabetes, and heart disease are the most common cause of death and disability.The World Health Organization (WHO) estimates that cancer will account for nearly one in six deaths worldwide by 2020, making it a leading cause of death.Biopharmaceuticals based on proteins effectively treat various cancers.Major issues include an increase in tobacco use, smoking habits, secondhand smoke exposure, poor diets, excessive alcohol consumption, and a lack of physical activity as a result of a sluggish lifestyle.According to the American Heart Association, cardiovascular disease (CVD) causes death every second in the United States.Invizius and 3P Biopharmaceuticals, two biotech companies, have developed novel technology for cardiovascular disease patients on hemodialysis. The biopharmaceuticals market is expected to expand between 2024 and 2031 as a result of the rising incidence of chronic diseases worldwide.
Biopharmaceuticals Market Restraints
On account of the low incomes and the high burden of healthcare costs, people in developing nations are unable to afford biomedicines and therapies. This may prevent the market from expanding significantly in the forecast period. In 2020, as per Joined Country Improvement Program, 1.3 billion individuals which is 22% of the all-out populace are living in neediness. They are unable to acquire better healthcare facilities because of their poor financial situation. Due to a lack of high-quality healthcare infrastructure, half of the world's population is unable to access essential medical facilities, according to the World Health Organization(WHO).The biopharmaceuticals market is experiencing difficulties as a result of these issues.
Request Free Customization of this report to help us to meet your business objectives.
Global Biopharmaceuticals Market Competitive Landscape
There are numerous major players in the highly competitive biopharmaceuticals market. Some mid-size and small businesses are expanding their geographical reach as a result of technological advancements and product innovations. Players such as Pfizer Inc., and AstraZeneca PLC both have a large share of the biopharmaceutical market and are involved in a variety of strategic alliances, including acquisitions and partnerships, to expand their product lines.
Biopharmaceuticals Market Top Players Company Profile
- Pfizer, Inc.
- F. Hoffmann-La Roche AG
- Johnson & Johnson Services, Inc.
- Sanofi
- Amgen Inc.
- AbbVie Inc.
- Merck & Co., Inc.
- Biogen Idec
- Bayer AG
- Eli Lilly and Company
- Novartis AG
Biopharmaceuticals Market Recent Developments
- In March 2024, Gennova Biopharmaceuticals Ltd announced the launch of paediatric pack size of pegaspargase, HAMSYL Junior, which will now be available in a 1500 IU pack size. This advances healthcare for Indian children suffering from an orphan disease called acute lymphoblastic leukaemia (ALL), a rare and challenging form of blood cancer primarily affecting children.
- In March 2022, Pfizer, Inc declared the completion of its gain of Arena Pharmaceuticals – a company working on developing innovative potential therapies for the treatment of numerous immuno-inflammatory ailments. As per their mutual agreement, Arena Pharmaceuticals will supply Pfizer with a portfolio of vivid and promising therapeutic candidates in their development stages in different medical fields such as cardiology, dermatology, and gastroenterology to develop immune-inflammatory ailments for diseases such as Crohn’s disease, ulcerative colitis, alopecia areata, atopic dermatitis, and eosinophilic esophagitis.
- In May 2022, Roche announced a partnership with the Global Fund to support low and middle-income countries in strengthening critical diagnostic infrastructure to fight AIDS, TB, and malaria. This partnership includes the building of an effective process to collect, transport, test samples, and return results to patients for timely clinical intervention. The partnership will also involve new approaches to decrease the environmental and economic burden of healthcare waste produced during the testing process.
Global Biopharmaceuticals Key Market Trends
- The primary factor contributing to the rapid expansion of the biopharmaceuticals market is the successful therapeutic application of monoclonal antibodies and antibody derivatives. Cancer, rheumatoid arthritis, multiple sclerosis, and cardiovascular diseases are some of the conditions for which monoclonal antibodies can be used as therapeutic agents. Healthcare systems have been experiencing significant strain as a result of the COVID-19 outbreak. Researchers from all over the world are constantly trying to deal with this growing burden. As a result, demand for COVID-19-specific monoclonal antibodies is likely to soar. For instance, the Drug Controller General of India (DCGI) granted approval in July 2020 for the emergency treatment of cytokine release syndrome in patients with acute respiratory distress syndrome who are also infected with COVID-19 with an anti-CD6 IgG1 monoclonal antibody manufactured by Biocon Ltd. (India). In addition, the segment is anticipated to be driven by increasing FDA approvals and new product launches for various indications. For instance, MacroGenics' MARGENZATM was approved by the US Food and Drug Administration (FDA) in December 2020 for the treatment of pretreated metastatic HER2-positive breast cancer. For the treatment of relapsed or refractory multiple myeloma, the FDA approved GlaxoSmithKline's belantamab mafodotin-blmf (BLENREP) in August 2020. As a result, it is anticipated that the biopharmaceuticals market will expand significantly over the forecast period as a result of the aforementioned factors.
Global Biopharmaceuticals Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyzes the Data collected using Primary Exploratory Research backed by robust Secondary Desk research.
According to our biopharmaceuticals market analysis, the primary factor contributing to the rapid expansion of this market is the successful therapeutic application of monoclonal antibodies and antibody derivatives. The increase in prevalence of cardiac issues as a result of lifestyle changes and irregular eating and sleeping habits are likely to increase the patient pool for different chronic diseases. This is projected to aid in expansion of the global biopharmaceuticals market in the long run. Regionwise, North America is expected to dominate the market in the coming years. The recombinant protein segment held the largest share of the market.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 377.87 million |
| Market size value in 2031 | USD 742.87 million |
| Growth Rate | 7.80% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Million |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Global Biopharmaceuticals Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Global Biopharmaceuticals Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Global Biopharmaceuticals Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Global Biopharmaceuticals Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Global Biopharmaceuticals Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Global Biopharmaceuticals Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
Global Biopharmaceuticals Market Report Snapshots
Want to customize this report?
Our industry expert will work with you to provide you with customized data in a short amount of time.
REQUEST FREE CUSTOMIZATION
USA (+1) 617-230-0741
